Posted by Michael Wonder on 02 Mar 2021
Drug industry pushes FDA to solve growing inspection backlog
2 March 2021 - Inspections are a vital tool to ensure the safety of new drugs as well as medicines already on the market.
The FDA is under increasing pressure from the pharmaceutical industry to address the growing backlog of drug inspections — nearly a year after COVID-19 prompted the agency to halt most plant visits.
